Shiral S. Gangadin

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Marieke Begemann, Ilse A. Thompson, Wim Veling et al. · Trials · 2020 · 68 citations · Full text

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse

Iris E. Sommer, Bodyl A. Brand, Shiral S. Gangadin et al. · Schizophrenia Bulletin · 2022 · 57 citations · Full text

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial

Iris E. Sommer, Shiral S. Gangadin, Lot D. de Witte et al. · Schizophrenia Bulletin · 2021 · 46 citations · Full text

Psychotropic Medication, Psychopharmacology, Neuropsychiatry +18

Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis

Priscilla P. Oomen, Marieke Begemann, Bodyl A. Brand et al. · Psychological Medicine · 2021 · 41 citations · Full text

Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patients

Shiral S. Gangadin, Wiepke Cahn, Thomas W. Scheewe et al. · Journal of Psychiatric Research · 2021 · 27 citations · Full text

Hippocampus-midbrain-striatum Network, Brain Function, Brain Organization +20